Our references

From small patient registries to large scale studies with multiple centers across Europe.

ACE-Covid

A study investigating the effects of ACE-inhibitors in COVID-19 patients.

Axel Bauer Medical University of Innsbruck, Austria & Steffen Massberg, University Hospital Munich, Germany

Antibody COVID-19

A study that performs antibody tests for SARS-CoV-2 within 4000 employees in 11 Austrian trauma hospitals.

Wolfgang Schaden, Allgemeine Unfallversicherungsanstalt, Austria

ARO

ARO is an observational study of hemodialysis (HD) patients in Europe, aims to enhance our understanding of patient characteristics and practice patterns to improve patient outcome.

Fresenius Medical Care Facilities

ASCIS

A registry for patients with traumatic spinal cord injury (tSCI) in Austria

Georg Mattiassich, Paracelsus Medizinische Privatuniversität (PMU), Austria

AUGUR

A study for analysing makula degeneration in the area of Regensburg (Germany).

Iris Heid & Klaus Stark, Universitätsklinikum Regensburg, Germany

Cadochine Study



Jan Menne, Phenos GmbH, Germany

CooL-TreatS

Treatment Success with the CoolLoop® Cryoablation System - Post-Market Surveillance

AFreeze, Austria

Diabetes Landeck

Wilhelm Oberaigner, Establishing a complete registry with diabetes mellitus patients.

UMIT Hall, Austria

Endomed Study

A endometriosis study

Peter Widschwendter, Landeskrankenhaus Hall, Austria

Endometriosis Registry



Beata Seeber, Medical University of Innsbruck, Austria

FH-Register

The Austrian registry for hypercholesteremia.

Christoph Binder, Österreichischen Atherosklerosegesellschaft, Austria

GCKD

The German Chronic Kidney Disease (GCKD) study is a prospective observational national cohort study. It aims to enroll a total of >5000 patients with CKD of various aetiologies, who are under nephrological care, and to follow them for up to 10 years.

Kai-Uwe Eckardt (Speaker), Charité Berlin, Germany

HEVACC Studie

Heterologe Impfung mit Vaxzevria (ChAdOx1-S, AstraZeneca) gefolgt von Comirnaty (BNT162b2, Pfizer)

Dorothee von Laer, Institute of Virology, Medical University of Innsbruck, Austria

HFIRONT

Randomized double-blind explorative controlled clinical trial analysing the effects of ferric carboxymaltose in patients with iron deficiency and chronic heart failure (HFIRONT).

Lukas Lanser, Department of Internal Medicine II, Medical University of Innsbruck, Austria

INN-WOP

Phase II trial exploring combined neoadjuvant therapy.

Georg Pall, Department of Internal Medicine V, Medical University of Innsbruck, Austria

Ischgl GWAS

A COVID-19 meta study study including the population of Ischgl.

Dorothee von Laer, Medical University of Innsbruck, Austria

MiflaPro

A study of Micronized purified Flavonoid-Fraction (MPFF) in the management of radiation proctitis.

Irmgard Kronberger, Medical University of Innsbruck, Austria

Mronj

A study of the incidence and prevalence of drug-associated necrosis

Johannes Laimer & Christine Brunner, Medical University of Innsbruck, Austria

ncRNA-Pain

A project sets out to further explore the biological mechanisms underlying chronic pain.

Medical University of Innsbruck, Austria
University Hospital of Würzburg, Germany
University Medical Center of the Johannes Gutenberg University Mainz, Germany
CEITEC Masaryk University Brno – University Hospital, Czech Republic

Neurowave

A study to measure the effect of extracorporeal shock wave therapy.

Wolfang Schaden, Allgemeine Unfallversicherungsanstalt, Austria

non-HFE

The aim of the non-HFE registry is to collect structured information on the clinical presentation, biochemistry, radiology, family history, genetics and histology of patients with non-HFE hemochromatosis, ferroportin disease and aceruloplasminemia

Heinz Zoller, Medical University of Innsbruck, Austria

PEARL

Prospektive Beobarchtungsstudie (NiS) zur Evaluierung des Einflusses von Migraenetherapien auf die Lebensqualitaet in der klinischen Routine.

Gregor Brössner, Department of Neurology, University Hospital Innsbruck, Austria

REDUCE Studie

Effekt deR BNT162b2-Impfung im RahmEn Der Impfiniative Bezirk Schwaz aUf die Inzidenz von SARS-CoV-2 InfektionEn

Peter Willeit, Department of Neurology & Neurosurgery, Medical University of Innsbruck

ROC Registry

A registry study of platinum-sensitive relapsed epithelial ovarian cancer (ROC) patients in Austria.

Christian Marth, Medical University of Innsbruck, Austria

Sapaldia

SAPALDIA (Swiss study on Air Pollution and Lung Disease in adults) is a cohort study in the Swiss population, which studies the effects of air pollution on the respiratory and cardiovascular health in adults.

Nicole Probst-Hensch, Swiss Tropical and Public Health Institute (Swiss TPH), Switzerland

Shieldvacc Studie

Immunantwort und Impfdurchbrüche nach zulassungskonformer Impfung mit Comirnaty (BNT162b2) gegen SARS-CoV-2 im Bezirk Schwaz.

Wegene Borena, Institute of Virology, Medical University of Innsbruck, Austria

Sophya 2

A study on leisure, exercise and children's health in Switzerland.

Nicole Probst-Hensch, Swiss Tropical and Public Health Institute (Swiss TPH), Switzerland

Stec Hus Registry



Medical University of Innsbruck, Austria

TirolGESUND



Martin Widschwendter, University of Innsbruck, Austria & University College London, United Kingdom